Geschatte realtime
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
7,06 USD | -3,02% | +0,21% | +4,81% |
18/03 | Fulcrum Therapeutics benoemt Patrick Horn tot medisch directeur | MT |
18/03 | Fulcrum Therapeutics, Inc. Kondigt wijzigingen in de leiding aan | CI |
Omzet 2024 * | 1,68 mln. 1,57 mln. | Omzet 2025 * | 11,67 mln. 10,89 mln. | Marktkapitalisatie | 452 mln. 422 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | -113 mln. -105 mln. | Nettowinst (verlies) 2025 * | -117 mln. -109 mln. | EV/omzet 2024 * | 235 x |
Nettoliquiditeiten 2024 * | 58,66 mln. 54,76 mln. | Nettoschuld 2025 * | 119 mln. 111 mln. | EV/omzet 2025 * | 48,9 x |
K/w-verhouding 2024 * |
-4,23
x | K/w-verhouding 2025 * |
-4,43
x | Werknemers | 76 |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 98,62% |
Recentste transcriptie over Fulcrum Therapeutics, Inc.
1 dag | -3,02% | ||
1 week | +0,21% | ||
Lopende maand | -25,05% | ||
1 maand | -24,97% | ||
3 maanden | +1,07% | ||
6 maanden | +116,36% | ||
Lopend jaar | +4,81% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Alex Sapir
CEO | Chief Executive Officer | 57 | 01-07-23 |
Alan Musso
DFI | Director of Finance/CFO | 61 | 07-08-23 |
Chief Tech/Sci/R&D Officer | - | 01-07-21 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
James Geraghty
BRD | Director/Board Member | 70 | 19-07-16 |
Director/Board Member | 70 | 01-12-16 | |
James Collins
BRD | Director/Board Member | 58 | 01-01-17 |
Naam | Gewicht | Volume | Vaira. 1 jan. | belegger rating |
---|---|---|---|---|
0.03% | 0 M€ | 0,00% | - | |
0.03% | 0 M€ | 0,00% | - | |
0.02% | 2 M€ | -.--% | ||
0.00% | 9 M€ | +6,00% | - |
Datum | Koers | Variatie | Volume |
---|---|---|---|
25-04-24 | 7,08 | -2,75% | 186 382 |
24-04-24 | 7,28 | -2,15% | 348 054 |
23-04-24 | 7,44 | +2,62% | 510 498 |
22-04-24 | 7,25 | +5,99% | 607 170 |
19-04-24 | 6,84 | -3,12% | 555 199 |
uitgestelde koers Nasdaq, 25 april 2024 om 17:19 uur
Meer koersenHerzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
+4,81% | 452 mln. | |
+0,62% | 43,84 mld. | |
+4,83% | 41,68 mld. | |
+45,32% | 41,25 mld. | |
-11,96% | 27,04 mld. | |
+5,81% | 25,53 mld. | |
-25,49% | 18,18 mld. | |
-4,00% | 12,29 mld. | |
+25,07% | 12,29 mld. | |
+6,98% | 11,15 mld. |